In the latest episode of "The Readout LOUD" podcast, Stelios Papadopolous, known as the "godfather" of biotech, discusses the biopharma industry, FDA, and China, while the hosts also cover recent biotech news including weight loss data from Structure Therapeutics and Eli Lilly, and FDA staff changes.
The podcast episode highlighted new weight loss data from Structure Therapeutics and Eli Lilly, which could be significant for those tracking advancements in obesity treatments and the potential for investment in these companies. Additionally, the discussion on FDA staff departures could signal regulatory shifts impacting biotech and pharmaceutical industries, warranting attention for those involved in drug approval processes.